通过预测矩阵识别多发性骨髓瘤早期死亡
研究基于Connect MM®注册库中2009年9月至2011年12月入组的1493例接受新药治疗的新诊断多发性骨髓瘤患者,其中102例(6.8%)发生早期死亡(诊断后≤6个月死亡)。多因素分析识别出年龄>75岁、较高ECOG体能状态评分、较低EQ-5D活动能力评分、较高ISS分期、较低血小板计数及既往高血压与早期死亡风险增加显著相关,肾功能不全有风险增加趋势。基于这些因素构建的预测矩阵可计算早期死亡风险,以辅助制定个体化治疗策略。
要点
- 新诊断多发性骨髓瘤患者中早期死亡(诊断后≤6个月死亡)发生率为6.8%(102/1493)。
- age>75岁、较高ECOG评分、较低EQ-5D活动能力评分、较高ISS分期、较低血小板计数及既往高血压与早期死亡风险增加显著相关。
- 肾功能不全与早期死亡风险增加呈趋势性关联。
核心结论
- 基于年龄、体能状态、活动能力评分、ISS分期、血小板计数和既往高血压构建的预测矩阵可用于计算新诊断多发性骨髓瘤患者的早期死亡风险,识别高危患者可能为实施个体化治疗策略提供机会。
研究设计与样本
- 研究为基于Connect MM®注册库的队列分析,纳入2009年9月至2011年12月注册、诊断后60天内入组且随访充分的1493例接受新药治疗的新诊断多发性骨髓瘤患者,进行单因素和多因素分析并构建logistic预测矩阵。
主要发现
- 1493例患者中102例(6.8%)发生早期死亡,1391例(93.2%)生存超过180天。
- 与早期死亡风险增加显著相关的基线因素包括年龄>75岁、较高的ECOG体能状态评分、较低的EQ-5D活动能力评分、较高的ISS分期、较低的血小板计数和既往高血压。
- 肾功能不全与早期死亡风险增加呈趋势性关联。
关键数值与推荐
- 早期死亡定义为诊断后≤6个月内死亡。
- 年龄>75岁、较高ECOG评分、较低EQ-5D活动能力评分、较高ISS分期、较低血小板计数、既往高血压为显著风险因素。
- 肾功能不全趋势性增加早期死亡风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Early mortality (EM; death ≤ 6 months from diagnosis) has been reported in several newly diagnosed multiple myeloma (NDMM) trials. Before the era of novel agents, the incidence was 10%-14%. Causes of death included infections/pneumonia, renal failure, refractory disease, and cardiac events. Staging systems, such as the revised International Staging System (r-ISS), and prognostic factors including cytogenetics, lactate dehydrogenase levels, and myeloma-specific factors, are useful to assess overall prognosis; however, they cannot predict EM. We evaluated patients treated with novel agents in the Connect MM® Registry and identified risk factors of the EM cohort. Eligible patients were enrolled in the registry within 60 days of diagnosis. Univariate and multivariate analyses were conducted to evaluate associations between baseline characteristics and EM. Prediction matrices for EM were constructed from a logistic model. Between September 2009 and December 2011, 1493 patients were enrolled in the registry and had adequate follow-up. Of these patients, 102 (6.8%) had EM and 1391 (93.2%) survived for > 180 days. Baseline factors significantly associated with increased EM risk included age > 75 years, higher Eastern Cooperative Oncology Group performance status, lower EQ-5D mobility score, higher ISS stage, lower platelet count, and prior hypertension. Renal insufficiency trended toward increased EM risk. These risk factors were incorporated into a prediction matrix for EM. The EM prediction matrix uses differential weighting of risk factors to calculate EM risk in patients with NDMM. Identifying patients at risk for EM may provide new opportunities to implement patient-specific treatment strategies to improve outcomes.
引用
- Terebelo H, Srinivasan S, Narang M, et al. Recognition of early mortality in multiple myeloma by a prediction matrix. Am J Hematol. 2017. PMID: 28543165. doi:10.1002/ajh.24796
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。